The 2013 ‘Consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection’, released in July 2013, are the latest and most comprehensive of a series of important guidelines on antiretroviral therapy (ART) over the last decade from the World Health ...

With this update of the consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, WHO, for the first time, recommends that all people living with HIV be provided with antiretroviral therapy (ART). This will bring us one step closer to ...

The second edition of the World Health Organization (WHO) consolidated guidelines on the use of antiretrovirals (ARVs) updates the 2013 edition following an extensive review of evidence undertaken in 2015. Experience from country programmes, consultations with communities and modelling of potential impact have informed the ...

These consolidated guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the care of people living with HIV and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. They are structured along the continuum of HIV testing, care and ...

Objective: The objective was to evaluate community and healthcare worker (HCW) values and preferences on key topics to inform the development of the 2013 WHO consolidated guidelines for antiretroviral therapy in low and middle income countries. Design: Cross-sectional e-survey and e-forum discussion; focus group discussions (FGDs) Methods: ...

In June 2013, the WHO released consolidated guidelines on the use of antiretrovirals (ARVs) . The launch of these new guidelines is another milestone in the global endeavor toward universal access to antiretroviral treatment (ART) using the public health approach, pursuing the dual advantage of ...

By the end of 2012, the number of people receiving antiretroviral treatment (ART) in low and middle-income countries reached 9.7 million, including 7.2 million in sub-Saharan Africa. The bad news is that these figures represent only 65% of the global target of 15 million people ...

Objective: To determine the status of key national policies on the use of antiretroviral therapy (ART) at the time of the launch of the 2013 WHO consolidated guidelines as well as to track early progress towards adoption of these recommendations following dissemination. Design: Descriptive analysis of ...

Revisions to the April 8, 2015, version of the guidelines are largely based on findings from two large, randomized controlled trials that addressed the optimal time to initiate antiretroviral therapy (ART)—START (Strategic Timing of Antiretroviral Therapy) and TEMPRANO. Both studies demonstrated approximately a 50% reduction ...

The Prequalification of Medicines Programme (PQP) • A United Nations Programme managed by WHO • Started in March 2001 as a Pilot Project: Focus on HIV/AIDS • Partners included WHO, UNICEF, UNFPA, UNAIDS and supported by World Bank • Quickly expanded to include Tuberculosis, Malaria, Reproductive Health, Influenza and ...

PEPFAR’s Evolution. From Emergency Response to Sustainable Impact for an AIDS-free Generation. 2003-2007: PEPFAR 1 Emergency Response Delivering prevention, care and treatment services Building and strengthening health systems to deliver HIV services 2008-2012: PEPFAR 2 Shift to sustainable response Shared responsibility and country driven programs Scaling up core interventions (ART, PMTCT, and VMMC) ...

Purpose of the new PQ financing strategy: • Maintain the overall objective of PQ to provide assured safe, efficacious and quality drugs, vaccines, diagnostics and devices while increasing supply and access; • Need for an innovative, practical and sustainable funding approach for the WHO PQ programme; • Reduce ...

Currently does not include estimates of number of people who may need PrEP (e.g. number of IDUs at high risk of HIV acquisition) or TasP • Borrows average usage forecast from currently available forecasts till 2018 • Borrows epidemiological estimates from available estimates till 2018 • Assumptions: – Linear ...